about
Differential antitumor effects of vitamin D analogues on colorectal carcinoma in culture.Interactions between FGFR2 and RSK2-implications for breast cancer prognosis.Fibroblast growth factor signalling induces loss of progesterone receptor in breast cancer cells.CD151 in cancer progression and metastasis: a complex scenario.Tetraspanin CD151 mediates communication between PC3 prostate cancer cells and osteoblasts.Simplified, serine-rich theta-defensin analogues as antitumour peptides.Tetraspanin CD151 regulates transforming growth factor beta signaling: implication in tumor metastasis.CD151 regulates tumorigenesis by modulating the communication between tumor cells and endothelium.Tenascin C interacts with ecto-5'-nucleotidase (eN) and regulates adenosine generation in cancer cells.Ecto-5'-nucleotidase (eN, CD73) is coexpressed with metastasis promoting antigens in human melanoma cells.Expression of ecto-5'-nucleotidase (eN, CD73) in cell lines from various stages of human melanoma.Phosphorylation of RSK2 at Tyr529 by FGFR2-p38 enhances human mammary epithelial cells migration.Tetraspanin CD151 regulates glycosylation of (alpha)3(beta)1 integrin.Progesterone impairs Herceptin effect on breast cancer cells.FGFR2-Driven Signaling Counteracts Tamoxifen Effect on ERα-Positive Breast Cancer Cells.RSK1 promotes murine breast cancer growth and metastasis.MicroRNAs in regulation of triple-negative breast cancer progressionProfiling of Invasive Breast Carcinoma Circulating Tumour Cells-Are We Ready for the 'Liquid' Revolution?Clinical and Biological Significance of Gene Alteration and Estrogen Receptors Isoforms Expression in Breast Cancer PatientsTetraspanin CD151 impairs heterodimerization of ErbB2/ErbB3 in breast cancer cellsCD151 regulates expression of FGFR2 in breast cancer cells via PKC-dependent pathwaysBiphasic composite of calcium phosphate-based mesoporous silica as a novel bone drug delivery systemFGFs/FGFRs-dependent signalling in regulation of steroid hormone receptors - implications for therapy of luminal breast cancerSilica-Polymer Composites as the Novel Antibiotic Delivery Systems for Bone Tissue Infection
P50
Q35939528-F9D3ADFD-B9B0-4E31-9254-441C3C075C2CQ37396056-97158BB4-DA1B-4E73-B930-ACC7F52A6DA0Q37699170-CD80F798-9BED-4F7A-AAC6-85768BBA7EC6Q38163831-F575D84A-553F-40FA-AAD4-E91F7B53E9E3Q38712327-4AD95CA1-BEF9-45FB-86C3-39193348F989Q38724816-AF8A7EFC-AB9B-47F0-BB84-D38E384E6A7EQ39689422-1F8A0905-36CD-4F49-8D7B-EFFD99FE8814Q39837222-D4DAF759-2284-4534-BB61-24F4F2447BC6Q40038767-9A28A970-220E-404F-B284-00B372F4B747Q40215731-80616092-8D20-4282-B6A2-12C967827945Q40276687-3AF472D0-9F6F-46F8-921B-6DA9CC6D621DQ42206805-493FD183-66B9-420B-8C60-BF52D9E5B998Q46318751-FBB1BB8F-EE4E-440B-A8F4-049EBC92A400Q49639590-98790431-44E5-4BED-BADB-CCD98363B8B1Q50225023-EB9EFAB3-FF61-4FC1-86D6-9DE2A747FCB7Q52729347-D8C1C617-2F5C-4727-96C9-7DD51E41A623Q57111303-591150D4-CBE5-40DB-A20B-F738AA61521EQ64243735-D5CF24F7-E498-48DA-B1E2-C768CF37E46FQ64249317-B8E3C151-86A0-43F6-B1C6-0F566F3DC600Q91029964-79CC43D0-53F5-45F4-A7DC-27E92F7B7707Q91783964-5DEC0084-F527-42E8-B35E-C3930A21CEF1Q91835464-C51645EB-C7DD-4090-AACF-722780E7F5FCQ92379252-3D51E3A6-A2E7-4468-A641-282C71C12931Q92442969-C283E9CC-BEC8-4D4F-9BE3-C4A188401BA1
P50
description
researcher ORCID ID = 0000-0003-2583-7299
@en
wetenschapper
@nl
name
Rafal Sadej
@ast
Rafal Sadej
@en
Rafal Sadej
@es
Rafal Sadej
@nl
type
label
Rafal Sadej
@ast
Rafal Sadej
@en
Rafal Sadej
@es
Rafal Sadej
@nl
prefLabel
Rafal Sadej
@ast
Rafal Sadej
@en
Rafal Sadej
@es
Rafal Sadej
@nl
P1153
23052135100
P31
P496
0000-0003-2583-7299